Lichen sclerosus (LS) (also known as lichen sclerosus et atrophicus (LSA), white-spot disease) is an uncommon disease of unknown cause that results in white patches on the skin, which may cause scarring on and around genital skin.
Lichen Sclerosis (LS), Lichen Sclerosus et Atrophicus (LSA), Balanitis xerotica obliterans (BXO), Csillag's disease, White Spot Disease, kraurosis vulvae, lichen albus and lichen sclerosus et atrophicans. These are all different names for the same disease. Typically it's called LSA or BXO when it affects men, LS when it affects women or in referring to the disease in general.
LS was first described in 1887 by Dr. Hallopeau. In 1989 the International Society for the Study of Vulvovaginal Disease (ISSVD) officially proclaimed the name ‘lichen sclerosus’. Since then this is the official medical name for this disease.
Women are more commonly affected than men, particularly around and after menopause, but younger women or girls may also develop the disease. The condition most commonly occurs on the vulva and around the anus with ivory-white elevations that may be flat and glistening. There may be marked itching or the condition may be without any symptoms. There may also be thinning and shrinkage of the genital area that may make coitus painful.
In males, the disease may take the form of whitish thickening of the foreskin, which cannot be retracted easily. One study has revealed that 51 (98%) of 52 patients diagnosed with penile LS were uncircumcised. In men, this genital involvement has traditionally been known as balanitis xerotica obliterans (BXO).
On the non-genital skin, the disease may manifest as porcelain-white spots with small visible plugs inside the orifices of hair follicles or sweat glands on the surface. Thinning of the skin may also occur.
A biopsy is sometimes required for proper diagnosis, as LSA may be difficult to differentiate from condyloma. Histologically there's hyperkeratosis, atrophic epidermis, sclerosis of dermis and lymphocyte activity in dermis.
The disease often goes undiagnosed for several years, as it is sometimes not recognised and misdiagnosed as thrush or other problems and not correctly diagnosed until the patient is referred to a specialist when the problem does not clear up.
The disease can last for a considerably long time. Occasionally, "spontaneous cure" may ensue, particularly in young girls.
Lichen sclerosis does not cause cancer. However, skin that has been scarred as a result of lichen sclerosis is more likely to develop skin cancer. One to 4% of women with lichen sclerosis may develop vulvar carcinoma. For men it might be a major cause for tight foreskin, phimosis.
LS is usually treated with application of potent steroids, which may cause relief and prevent scarring. Other options are cryotherapy, and laser therapy. Occasionally, cancer may develop on the patches. Periodic consultation is therefore necessary.
LS may cause sufferers to feel depressed due to their condition, due to the pain caused. They may feel that they are 'not normal', 'can't have sex properly', 'the only one like this' and develop self-esteem issues. In such situations, it may be helpful to speak with a counsellor to work through such issues. Contact with support groups may also allow sufferers to realise that they are not alone, and that there are others who understand how they feel.
Marren P, Cherry C, Day A et al. Lichen Sclerosus: the patient, the hormon influenceonal i and disease impact (abstract) Br J Dermatol 1995;21:133.Lorenz B, Kaufman RH, Kutzner SK (1998). "Lichen sclerosus. Therapy with clobetasol propionate". J Reprod Med 43 (9): 790–4.
Marren P, Millard PR, Wojnarowska F.Vulval Lichen Sclerosus: lack of correlation between duration of clinical symptoms and histological appearances J Eur Acad Dermatol Venereol. 1997;(8):212-6Fischer G, Rogers M (1997). "Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid". Pediatr Dermatol 14 (3): 235–8. Powell J, Wojnarowska F (2001). "Childhood vulvar lichen sclerosus: an increasingly common problem". J. Am. Acad. Dermatol. 44 (5): 803–6. García-Bravo B, Sánchez-Pedreño P, Rodríguez-Pichardo A, Camacho F (1988). "Lichen sclerosus et atrophicus. A study of 76 cases and their relation to diabetes". J. Am. Acad. Dermatol. 19 (3): 482–5. Bracco GL, Carli P, Sonni L, et al (1993). "Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation". J Reprod Med 38 (1): 37–40. Mazdisnian F, Degregorio F, Mazdisnian F, Palmieri A (1999). "Intralesional injection of triamcinolone in the treatment of lichen sclerosus". J Reprod Med 44 (4): 332–4. Sideri M, Origoni M, Spinaci L, Ferrari A (1994). "Topical testosterone in the treatment of vulvar lichen sclerosus". Int J Gynaecol Obstet 46 (1): 53–6. Ayhan A, Urman B, Yüce K, Ayhan A, Gököz A (1989). "Topical testosterone for lichen sclerosus". Int J Gynaecol Obstet 30 (3): 253–5. Bousema MT, Romppanen U, Geiger JM, et al (1994). "Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study". J. Am. Acad. Dermatol. 30 (2 Pt 1): 225–31. Hillemanns P, Untch M, Pröve F, Baumgartner R, Hillemanns M, Korell M (1999). "Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid". Obstet Gynecol 93 (1): 71–4. Assmann T, Becker-Wegerich P, Grewe M, Megahed M, Ruzicka T (2003). "Tacrolimus ointment for the treatment of vulvar lichen sclerosus". J. Am. Acad. Dermatol. 48 (6): 935–7. Böhm M, Frieling U, Luger TA, Bonsmann G (2003). "Successful treatment of anogenital lichen sclerosus with topical tacrolimus". Arch Dermatol 139 (7): 922–4. Goldstein AT, Marinoff SC, Christopher K (2004). "Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl". J Pediatr Adolesc Gynecol 17 (1): 35–7. Rouzier R, Haddad B, Deyrolle C, Pelisse M, Moyal-Barracco M, Paniel BJ (2002). "Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus". Am. J. Obstet. Gynecol. 186 (1): 49–52. Abramov Y, Elchalal U, Abramov D, Goldfarb A, Schenker JG (1996). "Surgical treatment of vulvar lichen sclerosus: a review". Obstet Gynecol Surv 51 (3): 193–9.
Genital atrophy common after stopping HT: the dyspareunia many women experience has more to do with introital stenosis than vaginal dryness.(Women's Health)
Apr 01, 2005; WHITE SULPHUR SPRINGS, W.VA. -- Within just 6-12 months of discontinuing hormone therapy, more than 96% of postmenopausal women...